Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-08-21
1994-10-18
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, A61K 3700, A61K 3738, A61K 3724
Patent
active
053568761
ABSTRACT:
A method of terminating pregnancy in mammals is described by a novel application of the common fertility-promoting hormone known as human menopausal gonadotropin. A single injection of this gonadotropic hormone as early as the first day of conception can terminate pregnancy.
REFERENCES:
K. M. Doody and Carr, B. R. "Menstrual Cycle Disorders," Obstetrics and Gynocology of North America, vol. 17, No. 2, Jun. 1990.
Shohavu, Z. et al., "Early Miscarriage and Fetal . . . Intrafullopian Transfer," Fertility and Sterility, vol. 56 No. 2, Jan., 1990.
W. H. Yang and M. C. Chang "Interruption of Pregnancy . . . of PMS and hCG," Endocrundogy 83, pp. 217-224 1968.
Nakamura et al., "The pulsatile, subculareous administration . . . Nippon Sanka Fujinka", vol. 39, No. 12, pp. 2157-2164, 1987.
Gapo et al., "Menstrual Induction with Solproston" Prostaglandins, vol. 24, No. 5 pp. 657-665, 1982.
Lee Lester L.
Touzeau P. Lynn
Trinity University
LandOfFree
Methods of terminating pregnancy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of terminating pregnancy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of terminating pregnancy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2372469